132 related articles for article (PubMed ID: 8818179)
1. Analysis and use of qualitative data.
Sidani S; Sechrest L
NIDA Res Monogr; 1996; 166():292-309. PubMed ID: 8818179
[No Abstract] [Full Text] [Related]
2. Compensating for deficiencies in perinatal data sets: parametric perspectives.
Tippetts AS; Marques PR
NIDA Res Monogr; 1996; 166():272-91. PubMed ID: 8818178
[No Abstract] [Full Text] [Related]
3. Recruitment and retention of adolescent women in drug treatment research.
Palinkas LA; Atkins CJ; Noel P; Miller C
NIDA Res Monogr; 1996; 166():87-109. PubMed ID: 8818167
[No Abstract] [Full Text] [Related]
4. Critiquing qualitative research.
Beck CT
AORN J; 2009 Oct; 90(4):543-54. PubMed ID: 19801006
[TBL] [Abstract][Full Text] [Related]
5. Introduction to the Perinatal-20 treatment research demonstration program.
Rahdert ER
NIDA Res Monogr; 1996; 166():1-5. PubMed ID: 8818161
[No Abstract] [Full Text] [Related]
6. Computer analysis of qualitative data.
Fritz RB
NIDA Res Monogr; 1990; 98():59-79. PubMed ID: 2234008
[No Abstract] [Full Text] [Related]
7. Building bridges: treatment research partnerships in the community.
Chasnoff IJ; Marques PR; Strantz IH; Farrow J; Davis S
NIDA Res Monogr; 1996; 166():6-21. PubMed ID: 8818162
[No Abstract] [Full Text] [Related]
8. Discussion: measurement issues in the study of effects of substance abuse in pregnancy.
Coles CD
NIDA Res Monogr; 1992; 117():248-58. PubMed ID: 1620200
[No Abstract] [Full Text] [Related]
9. Methodological issues in prevention research on drug use and pregnancy.
Gilchrist LD; Gillmore MR
NIDA Res Monogr; 1992; 117():1-17. PubMed ID: 1620189
[No Abstract] [Full Text] [Related]
10. Methadone.
Bell DS
Med J Aust; 1978 May; 1(9):505-6. PubMed ID: 672748
[No Abstract] [Full Text] [Related]
11. Role of biologic markers in epidemiologic studies of prenatal drug exposure: issues in study design.
Bracken MB; Leaderer B; Belanger K
NIDA Res Monogr; 1992; 117():41-60. PubMed ID: 1620210
[No Abstract] [Full Text] [Related]
12. The epidemiology of drug abuse: current issues. Applications of indicator data (epidemics).
Greene MH
NIDA Res Monogr; 1977 Mar; (10):206-24. PubMed ID: 405603
[No Abstract] [Full Text] [Related]
13. Jail won't cure addiction.
Murphy K
Am J Nurs; 1995 Aug; 95(8):18. PubMed ID: 7631650
[No Abstract] [Full Text] [Related]
14. Case management: a method of addressing subject selection and recruitment issues.
LaFazia MA; Kleyn J; Lanz J; Hall T; Nyrop K; Stark KD; Hansen C; Watts DH
NIDA Res Monogr; 1996; 166():52-67. PubMed ID: 8818165
[No Abstract] [Full Text] [Related]
15. Measures of pregnant, drug-abusing women for treatment research.
Selden AM
NIDA Res Monogr; 1992; 117():194-211. PubMed ID: 1620197
[No Abstract] [Full Text] [Related]
16. Discussion: dilemmas in research in perinatal addiction--intervention issues.
Finnegan LP
NIDA Res Monogr; 1992; 117():344-8. PubMed ID: 1620206
[No Abstract] [Full Text] [Related]
17. Who is it going to be? Subject selection issues in prenatal drug exposure research.
Fried PA
NIDA Res Monogr; 1992; 117():121-36. PubMed ID: 1620191
[No Abstract] [Full Text] [Related]
18. Subject recruitment and retention for longitudinal research: practical considerations for a nonintervention model.
Streissguth AP; Guinta CT
NIDA Res Monogr; 1992; 117():137-54. PubMed ID: 1620192
[No Abstract] [Full Text] [Related]
19. Determining drug use patterns among women: the value of qualitative research methods.
Sterk-Elifson C
NIDA Res Monogr; 1995; 157():65-83. PubMed ID: 8684443
[No Abstract] [Full Text] [Related]
20. Methodological issues in obtaining and managing substance abuse information from prenatal patients.
Sokol RJ; Ager JW; Martier SS
NIDA Res Monogr; 1992; 117():80-97. PubMed ID: 1620212
[No Abstract] [Full Text] [Related]
[Next] [New Search]
